198 related articles for article (PubMed ID: 15352551)
1. Molecular basis of quinolone resistance in Escherichia coli from wild birds.
Jiménez Gómez PA; García de los Rios JE; Rojas Mendoza A; de Pedro Ramonet P; García Albiach R; Reche Sainz MP
Can J Vet Res; 2004 Jul; 68(3):229-31. PubMed ID: 15352551
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
3. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
4. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
[TBL] [Abstract][Full Text] [Related]
5. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
6. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Bansal S; Tandon V
Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
[TBL] [Abstract][Full Text] [Related]
7. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
Li Q; Bi X; Diao Y; Deng X
Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
[TBL] [Abstract][Full Text] [Related]
8. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
Beckmann L; Müller M; Luber P; Schrader C; Bartelt E; Klein G
J Appl Microbiol; 2004; 96(5):1040-7. PubMed ID: 15078520
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance.
Hirose K; Kawasaki Y; Kotani K; Abiko K; Sato H
J Vet Med B Infect Dis Vet Public Health; 2004 May; 51(4):169-75. PubMed ID: 15228551
[TBL] [Abstract][Full Text] [Related]
10. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
Pasquali F; Manfreda G
Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
[TBL] [Abstract][Full Text] [Related]
11. Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China.
Yang H; Chen S; White DG; Zhao S; McDermott P; Walker R; Meng J
J Clin Microbiol; 2004 Aug; 42(8):3483-9. PubMed ID: 15297487
[TBL] [Abstract][Full Text] [Related]
12. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
14. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
McIver C; Hogan T; White P; Tapsall J
Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA.
Angelakis E; Biswas S; Taylor C; Raoult D; Rolain JM
J Antimicrob Chemother; 2008 Jun; 61(6):1252-5. PubMed ID: 18334491
[TBL] [Abstract][Full Text] [Related]
16. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
Pasquali F; Rossi M; Manfreda G; Zanoni R
Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
Gibson JS; Cobbold RN; Kyaw-Tanner MT; Heisig P; Trott DJ
Vet Microbiol; 2010 Nov; 146(1-2):161-6. PubMed ID: 20471187
[TBL] [Abstract][Full Text] [Related]
19. Resistance mechanism against fluoroquinolones in Mycoplasma hyopneumoniae field isolates.
Vicca J; Maes D; Stakenborg T; Butaye P; Minion F; Peeters J; de Kruif A; Decostere A; Haesebrouck F
Microb Drug Resist; 2007; 13(3):166-70. PubMed ID: 17949302
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets.
Costa D; Poeta P; Sáenz Y; Coelho AC; Matos M; Vinué L; Rodrigues J; Torres C
Vet Microbiol; 2008 Feb; 127(1-2):97-105. PubMed ID: 17870255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
